491 related articles for article (PubMed ID: 26303227)
1. Oligogenic inheritance of optineurin (OPTN) and C9ORF72 mutations in ALS highlights localisation of OPTN in the TDP-43-negative inclusions of C9ORF72-ALS.
Bury JJ; Highley JR; Cooper-Knock J; Goodall EF; Higginbottom A; McDermott CJ; Ince PG; Shaw PJ; Kirby J
Neuropathology; 2016 Apr; 36(2):125-34. PubMed ID: 26303227
[TBL] [Abstract][Full Text] [Related]
2. Mutations of optineurin in amyotrophic lateral sclerosis.
Maruyama H; Morino H; Ito H; Izumi Y; Kato H; Watanabe Y; Kinoshita Y; Kamada M; Nodera H; Suzuki H; Komure O; Matsuura S; Kobatake K; Morimoto N; Abe K; Suzuki N; Aoki M; Kawata A; Hirai T; Kato T; Ogasawara K; Hirano A; Takumi T; Kusaka H; Hagiwara K; Kaji R; Kawakami H
Nature; 2010 May; 465(7295):223-6. PubMed ID: 20428114
[TBL] [Abstract][Full Text] [Related]
3. Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders.
Hortobágyi T; Troakes C; Nishimura AL; Vance C; van Swieten JC; Seelaar H; King A; Al-Sarraj S; Rogelj B; Shaw CE
Acta Neuropathol; 2011 Apr; 121(4):519-27. PubMed ID: 21360076
[TBL] [Abstract][Full Text] [Related]
4. Multiple Proteinopathies in Familial ALS Cases With Optineurin Mutations.
Ayaki T; Ito H; Komure O; Kamada M; Nakamura M; Wate R; Kusaka H; Yamaguchi Y; Li F; Kawakami H; Urushitani M; Takahashi R
J Neuropathol Exp Neurol; 2018 Feb; 77(2):128-138. PubMed ID: 29272468
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation.
Ito H; Nakamura M; Komure O; Ayaki T; Wate R; Maruyama H; Nakamura Y; Fujita K; Kaneko S; Okamoto Y; Ihara M; Konishi T; Ogasawara K; Hirano A; Kusaka H; Kaji R; Takahashi R; Kawakami H
Acta Neuropathol; 2011 Aug; 122(2):223-9. PubMed ID: 21644038
[TBL] [Abstract][Full Text] [Related]
6. [Identification of a new causative gene of amyotrophic lateral sclerosis; optineurin].
Maruyama H
Rinsho Shinkeigaku; 2012; 52(1):1-5. PubMed ID: 22260971
[TBL] [Abstract][Full Text] [Related]
7. Optineurin Deficiency and Insufficiency Lead to Higher Microglial TDP-43 Protein Levels.
Prtenjaca N; Rob M; Alam MS; Markovinovic A; Stuani C; Buratti E; Munitic I
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743272
[TBL] [Abstract][Full Text] [Related]
8. Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism.
Keller BA; Volkening K; Droppelmann CA; Ang LC; Rademakers R; Strong MJ
Acta Neuropathol; 2012 Nov; 124(5):733-47. PubMed ID: 22941224
[TBL] [Abstract][Full Text] [Related]
9. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ
Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854
[TBL] [Abstract][Full Text] [Related]
10. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease.
Pottier C; Bieniek KF; Finch N; van de Vorst M; Baker M; Perkersen R; Brown P; Ravenscroft T; van Blitterswijk M; Nicholson AM; DeTure M; Knopman DS; Josephs KA; Parisi JE; Petersen RC; Boylan KB; Boeve BF; Graff-Radford NR; Veltman JA; Gilissen C; Murray ME; Dickson DW; Rademakers R
Acta Neuropathol; 2015 Jul; 130(1):77-92. PubMed ID: 25943890
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism.
Shen WC; Li HY; Chen GC; Chern Y; Tu PH
Autophagy; 2015 Apr; 11(4):685-700. PubMed ID: 25484089
[TBL] [Abstract][Full Text] [Related]
12. An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline.
Troakes C; Maekawa S; Wijesekera L; Rogelj B; Siklós L; Bell C; Smith B; Newhouse S; Vance C; Johnson L; Hortobágyi T; Shatunov A; Al-Chalabi A; Leigh N; Shaw CE; King A; Al-Sarraj S
Neuropathology; 2012 Oct; 32(5):505-14. PubMed ID: 22181065
[TBL] [Abstract][Full Text] [Related]
13. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.
Al-Sarraj S; King A; Troakes C; Smith B; Maekawa S; Bodi I; Rogelj B; Al-Chalabi A; Hortobágyi T; Shaw CE
Acta Neuropathol; 2011 Dec; 122(6):691-702. PubMed ID: 22101323
[TBL] [Abstract][Full Text] [Related]
14. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.
Cooper-Knock J; Hewitt C; Highley JR; Brockington A; Milano A; Man S; Martindale J; Hartley J; Walsh T; Gelsthorpe C; Baxter L; Forster G; Fox M; Bury J; Mok K; McDermott CJ; Traynor BJ; Kirby J; Wharton SB; Ince PG; Hardy J; Shaw PJ
Brain; 2012 Mar; 135(Pt 3):751-64. PubMed ID: 22366792
[TBL] [Abstract][Full Text] [Related]
15. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.
Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE
Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573
[TBL] [Abstract][Full Text] [Related]
16. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
[TBL] [Abstract][Full Text] [Related]
17. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
[TBL] [Abstract][Full Text] [Related]
18. Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis.
Nakazawa S; Oikawa D; Ishii R; Ayaki T; Takahashi H; Takeda H; Ishitani R; Kamei K; Takeyoshi I; Kawakami H; Iwai K; Hatada I; Sawasaki T; Ito H; Nureki O; Tokunaga F
Nat Commun; 2016 Aug; 7():12547. PubMed ID: 27552911
[TBL] [Abstract][Full Text] [Related]
19. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
[TBL] [Abstract][Full Text] [Related]
20. Extensive molecular genetic survey of Taiwanese patients with amyotrophic lateral sclerosis.
Soong BW; Lin KP; Guo YC; Lin CC; Tsai PC; Liao YC; Lu YC; Wang SJ; Tsai CP; Lee YC
Neurobiol Aging; 2014 Oct; 35(10):2423.e1-6. PubMed ID: 24908169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
